Notice of a Pre-Application Webinar for RFA-CA-19-016 "Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54)"
Notice NOT-CA-18-110 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2018 Category: Research Source Type: funding

Notice of Change to Application Types Allowed for PAR-18-919 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)"
Notice NOT-CA-18-109 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2018 Category: Research Source Type: funding

Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-931 from the NIH Guide for Grants and Contracts. The Center to Reduce Cancer Health Disparities (CRCHD) of the National Cancer Institute (NCI), in partnership with the NCI Office of Cancer Centers (OCC), announces this opportunity to compete for administrative supplements to Cancer Center Support Grants (CCSGs; P30s) for NCI-designated Cancer Centers (CCs) to each recruit a Community Health Educator (CHE). The purpose of this administrative supplement funding opportunity is to support a strengthening of community outreach capacity by working through the National Outreach Network (NON). It is exp...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2018 Category: Research Source Type: funding

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
Funding Opportunity RFA-CA-19-002 from the NIH Guide for Grants and Contracts. The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments, and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers. ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 17, 2018 Category: Research Source Type: funding

Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
Funding Opportunity RFA-CA-18-029 from the NIH Guide for Grants and Contracts. The purpose of this RFA is to support early clinical trials consortia poised to efficiently evaluate the biologic effects of cancer preventive agents and to determine clinically-relevant correlates in order to advance their development for cancer prevention. The program objectives are: To efficiently design and conduct early phase clinical trials to assess the cancer preventive potential of NCI-sponsored agents of varying classes, many of which target molecules or processes known to be important during carcinogenesis. These trials include phase...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2018 Category: Research Source Type: funding

Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Coordinating Center (DMACC) (U24 Clinical Trials Required)
Funding Opportunity RFA-CA-18-030 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is a part of the National Cancer Institute (NCI) initiative intended to support Cancer Prevention Clinical Trials Network (CP-CTNet). The goals for the CP-CTNet include: Design and conduct early phase clinical trials to assess the safety, tolerability, and cancer preventive potential of agents and interventions of varying classes, many of which target molecules or processes known to be important during carcinogenesis. These trials include phase 0 (microdosing), phase I (dose-finding), and phase II (pr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 14, 2018 Category: Research Source Type: funding

Notice of Change to Key Dates in PAR-18-249 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)"
Notice NOT-CA-18-093 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 13, 2018 Category: Research Source Type: funding

Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-919 from the NIH Guide for Grants and Contracts. This purpose of this Funding Opportunity Announcement (FOA) is to provide a mechanism of support to research organizations interested in clinically translating already optimized quantitative imaging software tools capable of measuring or predicting the response of cancer to clinical therapies, or in translating imaging software tools for planning and validating radiation therapy treatment strategies in clinical trials. The quantitative software tools must have been developed and optimized during a performance period in the Quantitative Imaging Net...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 12, 2018 Category: Research Source Type: funding

Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-016 from the NIH Guide for Grants and Contracts. The FOA will focus on fusion oncoproteins found in tumors that have high risk of treatment failure and for which there has been little progress in identifying targeted agents. Responsive applications can focus on any fusion oncoprotein in pediatric solid tumors or on NUP98 fusion proteins that occur in young children with acute myelogenous leukemia (AML). However, greater preference will be given to applications focused on PAX-FOXO (alveolar rhabdomyosarcoma), C11orf95RELA (ependymoma), or NUP98 fusion proteins. (Source: NIH Funding Opportuniti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2018 Category: Research Source Type: funding

Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional).
Funding Opportunity RFA-CA-19-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative (https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative) that is intended to accelerate cancer research. The purpose of this FOA is to develop, test, and evaluate interventions and implementation approaches, or adapt existing approaches, to improve patient/provider/family risk communication and decision making for individuals and families with an inherited susceptibility to cancer. Specifically, this FOA targets the fol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 10, 2018 Category: Research Source Type: funding

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-913 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Availa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2018 Category: Research Source Type: funding

Notice of Termination of PAR-16-138 "Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)"
Notice NOT-CA-18-105 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2018 Category: Research Source Type: funding

Notice of Termination of PAR-16-139 "Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)"
Notice NOT-CA-18-106 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2018 Category: Research Source Type: funding

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-911 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major go...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2018 Category: Research Source Type: funding

Notice of Change to Application Review Information in PAR-18-801 "Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)"
Notice NOT-CA-18-103 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2018 Category: Research Source Type: funding

Notice of Change to Application Review Information in PAR-18-802, "Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)"
Notice NOT-CA-18-104 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2018 Category: Research Source Type: funding

Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)
Funding Opportunity RFA-CA-18-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to facilitate the design, conduct, and completion of clinical trials for improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals. To serve this goal, the FOA will support a network of international collaborative sites conducting meritorious and appropriately designed prevention clinical trials in the Latin American and Caribbean (LAC) region via a U54 Partnership Centers mechanism. Each proposed U54 Partnership Cen...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 28, 2018 Category: Research Source Type: funding

Improving Smoking Cessation Interventions among People Living with HIV (R01 and R21 Clinical Trial Optional)
Funding for research designed to optimize smoking cessation treatment among people living with HIV. Research may address the behavioral and sociocultural factors and conditions that are associated with cigarette smoking among people living with HIV and may also address smoking-related health disparities. Geographic coverage: Nationwide -- National Cancer Institute, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - August 27, 2018 Category: American Health Source Type: funding

Notice of Correction to Key Dates for PAR-17-206 "Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)"
Notice NOT-CA-18-097 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2018 Category: Research Source Type: funding

Notice of Correction to Key Dates for PAR-17-207 "Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01)"
Notice NOT-CA-18-098 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2018 Category: Research Source Type: funding

Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 - Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to establish centers of collaborating investigators with the goal of identifying and advancing research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Recommendation (B) tha...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 13, 2018 Category: Research Source Type: funding

Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 - No Clinical Trial Allowed)
Funding Opportunity RFA-CA-19-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The overall goal of this FOA and the companion FOA, RFA-CA-19-012, is to establish a network of collaborating investigators to identify and advance research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BR...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 13, 2018 Category: Research Source Type: funding

Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Required)
Funding Opportunity RFA-CA-19-017 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to increase case ascertainment and appropriate follow-up care, optimizing the delivery of evidence-based healthcare for individuals at high risk of cancer due to an inherited genetic susceptibility. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP) Recommendation G: "To realize the potential of ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 10, 2018 Category: Research Source Type: funding

Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed)
Funding Opportunity RFA-CA-18-012 from the NIH Guide for Grants and Contracts. Through this limited competition Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) solicits a single application for the continuation of the AIDS and Cancer Specimen Resource (ACSR). The eligible applicant institutions (which are the two current NCI-supported ACSR lead institutions) are expected to maintain the cooperative group structure and the activities of the ACSR. The primary objective of the ACSR will be to acquire, store, and equitably distribute tumor tissues, biological fluids, and associated demographic data...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2018 Category: Research Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
Funding Opportunity PAR-18-892 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 7, 2018 Category: Research Source Type: funding

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-893 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 7, 2018 Category: Research Source Type: funding

NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-888 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 2, 2018 Category: Research Source Type: funding

NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-887 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 2, 2018 Category: Research Source Type: funding

NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA. It is expected that the OIA would provide extended fu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 30, 2018 Category: Research Source Type: funding

Notice of Change in Key Dates in PA-18-842 "Administrative Supplements to Support Cancer Disparity Collaborative Research"
Notice NOT-CA-18-090 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 26, 2018 Category: Research Source Type: funding

Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-874 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage exploratory/ developmental research on biologic factors that mediate the differences in prevalence and severity of Dental, Oral, and Craniofacial (DOC)-related diseases and conditions in oral health disparities populations. It is long recognized that certain racial and ethnic populations suffer an increased burden of DOC diseases and conditions, such as oral/oropharyngeal cancers, early childhood caries (ECC), dental caries, and periodontitis. For each of these diseases, sub...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 25, 2018 Category: Research Source Type: funding

Update on the National Cancer Institute (NCI) "PREVENT Cancer Preclinical Drug Development Program: Preclinical Services for Biopharmaceutical Product Development and Manufacturing "
Notice NOT-CA-18-096 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 25, 2018 Category: Research Source Type: funding

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Funding Opportunity PAR-18-869 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 24, 2018 Category: Research Source Type: funding

NCI Request for Information (RFI): Input on Development of an NCI Cancer Biomarker Data Aggregator
Notice NOT-CA-18-095 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 23, 2018 Category: Research Source Type: funding

Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-RM-18-030 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to establish one or two centers that can rapidly generate high quality whole genome sequence and variant data from a large number of human specimens representing two types of pediatric conditions - childhood cancers and structural birth defects. All sequence data generated under this FOA will be re-processed and harmonized by the Gabriella Miller Kids First Pediatric Data Resource Center (Kids First DRC), which is also charged with building a public-facing, web-based portal that will...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 23, 2018 Category: Research Source Type: funding

Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research (Admin Supp - Clinical Trial Not Allowed)
Funding Opportunity PA-18-852 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to incentivize collaborative, multidisciplinary research across a broad area of challenging topics in basic cancer biology. These supplement applications must propose a collaboration between at least two researchers, one being the PI of the parent NCI grant. Awarded supplements will leverage and extend currently funded cancer research in the parent grant. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 5, 2018 Category: Research Source Type: funding

Notice of Availability of Administrative Supplements for Integrative Data Analysis to extend Research in Cancer Control and Population Sciences (Admin Supp Clinical Trial - Optional)
Notice NOT-CA-18-087 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2018 Category: Research Source Type: funding

Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Funding Opportunity PA-18-842 from the NIH Guide for Grants and Contracts. The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide-ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and po...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2018 Category: Research Source Type: funding

Notice of Availability of Administrative Supplements for NCI Grant and Cooperative Agreement Awards to Support Pediatric Cancer Control Research Across the Lifespan (Admin Supp Clinical Trial Optional)
Notice NOT-CA-18-088 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2018 Category: Research Source Type: funding

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)
Funding Opportunity PAR-18-841 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials. The scientific goals of this FOA are to: (a) perform the appropriate optimization of the pre-clinical quantitative imaging methods, (b) implement the optimized methods in the co-clinical trial, and finally (c) populate a web-accessible research resource with all ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2018 Category: Research Source Type: funding

Notice of Change in Expiration Date and Application and Submission Information for PAR-16-139 "Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)"
Notice NOT-CA-18-082 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding

Notice of Change in Expiration Date and Application and Submission Information for PAR-16-138 "Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)"
Notice NOT-CA-18-081 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding

Notice of Correction to NOT-CA-18-071 "Notice of Intent to Publish a Funding Opportunity Announcement for the Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54)"
Notice NOT-CA-18-086 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding

Notice of Change to Application Types Allowed in PA-17-239 "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)"
Notice NOT-CA-18-080 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2018 Category: Research Source Type: funding

Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)
Funding Opportunity RFA-CA-18-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to support the Cooperative Human Tissue Network (CHTN). The goal for CHTN is to collect and distribute high quality human tissue specimens to facilitate basic and early translational cancer research, as well as assay development. The CHTN is designed as a unique biospecimen resource in that it is based on prospective collection and distribution of samples upon specific investigators requests. Samples to be collected from patients includ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 22, 2018 Category: Research Source Type: funding

End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness
Funding for research focused on identification of the key barriers to effective end-of-life and palliative care health literacy in diverse settings and populations, and to create novel strategies, interventions, and models of care to improve health literacy, with the goal of improving outcomes for individuals with serious, advanced illness and their families and caregivers. This program is featured in the Division of Cancer Control and Population Sciences Selected List of Funding Opportunities Relevant to Rural Cancer Control. Geographic coverage: Nationwide -- National Cancer Institute, National Institute of Nursing Resea...
Source: Funding opportunities via the Rural Health Information Hub - June 21, 2018 Category: American Health Source Type: funding

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 and R21)
Funding for intervention research designed to support caregivers of adult cancer patients, with the goals of optimized patient healthcare utilization, improved caregiver well-being, and improved patient physical health and psychosocial outcomes. This program is featured in the Division of Cancer Control and Population Sciences Selected List of Funding Opportunities Relevant to Rural Cancer Control. Geographic coverage: Nationwide -- National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - June 21, 2018 Category: American Health Source Type: funding

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 Clinical Trial Optional)
Grants to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life. This program is featured in the Division of Cancer Control and Population Sciences Selected List of Funding Opportunities Relevant to Rural Cancer Control. Geographic coverage: Nationwide -- National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - June 21, 2018 Category: American Health Source Type: funding

Dissemination and Implementation Research in Health (R01 and R03)
Funding for research that seeks to identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices into public health, clinical practice, and community settings. This program is featured in the Division of Cancer Control and Population Sciences Selected List of Funding Opportunities Relevant to Rural Cancer Control. Geographic coverage: Nationwide -- National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - June 20, 2018 Category: American Health Source Type: funding

Cancer-Related Behavioral Research through Integrating Existing Data (R01 and R21)
Funding for projects that seek to integrate two or more independent data sets to answer novel cancer control and prevention questions with the goal of encouraging applications that incorporate Integrative Data Analysis methods to study behavioral risk factors for cancer, including tobacco use, sedentary behavior, poor weight management, and lack of medical adherence to screening and vaccine uptake. This program is featured in the Division of Cancer Control and Population Sciences Selected List of Funding Opportunities Relevant to Rural Cancer Control. Geographic coverage: Nationwide -- National Cancer Institute, National I...
Source: Funding opportunities via the Rural Health Information Hub - June 20, 2018 Category: American Health Source Type: funding